CollPlant Biotechnologies Ltd.
CLGN
$2.29
-$0.1295-5.35%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -159.48% | 55.31% | 58.53% | |
| Total Depreciation and Amortization | -- | -2.14% | -1.25% | 2.42% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -12.18% | -32.17% | -14.43% | |
| Change in Net Operating Assets | -- | 211.31% | 271.71% | 255.88% | |
| Cash from Operations | -- | 79.96% | 81.59% | 79.83% | |
| Capital Expenditure | -- | 29.87% | 20.66% | 25.12% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -201.12% | -1,900.00% | -100.89% | |
| Cash from Investing | -- | 18.08% | 1.35% | -104.00% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -82.59% | -73.90% | -40.88% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -82.59% | -73.90% | -40.88% | |
| Foreign Exchange rate Adjustments | -- | 45.85% | 66.77% | 37.66% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 73.74% | 75.42% | -119.35% | |